| Dacomitinib studied in …STUDIED_INderived17 of 17show fewer |
|---|
| → studied in | NCT00728390Phase 1 · completed A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks · 17 trials list this drug (0 active) | — | — | Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01000025Phase 3 · completed PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer · 17 trials list this drug (0 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00768664Phase 2 · completed Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer · 17 trials list this drug (0 active) | — | — | Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00553254Phase 2 · completed Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer · 17 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00548093Phase 2 · completed PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib · 17 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00225121Phase 1 · completed Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors · 17 trials list this drug (0 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01112527Phase 2 · completed PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma · 17 trials list this drug (0 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00728468Phase 1 · completed A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients · 17 trials list this drug (0 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01152853Phase 2 · completed PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer · 17 trials list this drug (0 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01121575Phase 1 · completed A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer · 17 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769067Phase 2 · completed A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen · 17 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116843Phase 1/Phase 2 · completed Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment · 17 trials list this drug (0 active) | — | — | Malignant Oral Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01484847NA · completed A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma · 17 trials list this drug (0 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01449201Phase 2 · completed PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma · 17 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00971191Phase 1 · terminated A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804 · 17 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00783328Phase 1 · completed A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors · 17 trials list this drug (0 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01034748Phase 1 · completed A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers · 17 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |